6th May 2016 09:38
LONDON (Alliance News) - Immunodiagnostic Systems Holdings PLC on Friday said it has launched its IDS-iSYS 17-OH progesterone assay in the European market.
The IDS-iSYS 17-OH progesterone assay measures a patient's 17-OH progesterone level and offers clinicians an easy, non-invasive way to diagnose disorders of the adrenal gland or the ovaries, such as Congenital Adrenal Hyperplasia or Polycystic Ovarian Syndrome.
Immunodiagnostic Systems said this is the first product to be released as part of its upcoming fertility portfolio.
Shares in the company were trading up 2.8% at 145.50 pence on Friday morning.
By Karolina Kaminska; [email protected] @KarolinaAllNews
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
IDH.L